Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
55.2M
-
Shares change
-
+1.49M
-
Total reported value, excl. options
-
$2.19B
-
Value change
-
+$48.6M
-
Put/Call ratio
-
0.58
-
Number of buys
-
88
-
Number of sells
-
-90
-
Price
-
$39.62
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q4 2021
221 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.2M shares
of 69.1M outstanding shares and own 79.85% of the company stock.
Largest 10 shareholders include FMR LLC (7.43M shares), BlackRock Inc. (4.7M shares), VANGUARD GROUP INC (4.28M shares), WELLINGTON MANAGEMENT GROUP LLP (3.61M shares), Capital Research Global Investors (3.39M shares), ALLIANCEBERNSTEIN L.P. (3.12M shares), Clearbridge Investments, LLC (2.24M shares), JANUS HENDERSON GROUP PLC (1.38M shares), RIVERBRIDGE PARTNERS LLC (1.11M shares), and abrdn plc (1.1M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.